| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CASCADIAN THERAPEUTICS INC | 103,800 | 447,000 | 0.15% | Call | |
| 2 | BRISTOL MYERS SQUIBB CO | 8,560 | 500,000 | 0.17% | ||
| 3 | BioPharmX Corporation | 1,342,000 | 502,000 | 0.17% | ||
| 4 | CYTOKINETICS INC | 54,879 | 667,000 | 0.22% | ||
| 5 | SYROS PHARMACEUTICALS INC | 63,596 | 773,000 | 0.26% | ||
| 6 | CHEMOCENTRYX INC | 118,000 | 873,000 | 0.29% | ||
| 7 | AGIOS PHARMACEUTICALS INC | 23,300 | 972,000 | 0.32% | ||
| 8 | DERMIRA INC COM | 43,200 | 1,310,000 | 0.44% | ||
| 9 | ADR - Nabriva Therapeutics AG- Usd | 264,773 | 1,578,000 | 0.53% | ||
| 10 | Egalet Corp | 222,300 | 1,701,000 | 0.57% | ||
| 11 | Syndax Pharmaceuticals Inc | 273,862 | 1,964,000 | 0.66% | ||
| 12 | Life Technologies Corp | 976,986 | 2,101,000 | 0.70% | ||
| 13 | KINDRED BIOSCIENCES INC | 571,126 | 2,427,000 | 0.81% | ||
| 14 | ADVERUM BIOTECHNOLOGIES INC | 874,447 | 2,536,000 | 0.85% | ||
| 15 | Atara Biotherapeutics Inc | 215,812 | 3,065,000 | 1.02% | ||
| 16 | FASTENAL CO | 2,537,026 | 6,368,000 | 2.13% | ||
| 17 | CHIMERIX INC | 1,415,687 | 6,512,000 | 2.17% | ||
| 18 | XENCOR INC COM | 375,000 | 9,870,000 | 3.30% | ||
| 19 | EDITAS MEDICINE INCORPORATED | 626,762 | 10,172,000 | 3.40% | ||
| 20 | ALLERGAN PLC | 50,000 | 10,501,000 | 3.51% | Call | |
| 21 | ACLARIS THERAPEUTICS INC COM | 414,000 | 11,236,000 | 3.75% | ||
| 22 | FIVE PRIME THERAPEUTICS INC | 298,712 | 14,968,000 | 5.00% | ||
| 23 | KURA ONCOLOGY INC | 2,611,906 | 15,410,000 | 5.15% | ||
| 24 | ARDELYX INC COM | 1,310,023 | 18,602,000 | 6.21% | ||
| 25 | THERAVANCE BIOPHARMA INC | 17,000,000 | 19,327,000 | 6.45% | PRN | |
| 26 | Ascendis Pharma | 975,700 | 19,748,000 | 6.60% | ||
| 27 | ALEXION PHARMACEUTIC | 162,200 | 19,845,000 | 6.63% | ||
| 28 | ASSEMBLY BIOSCIENCES INC | 2,943,164 | 35,759,000 | 11.94% | ||
| 29 | GALAPAGOS NV | 561,341 | 36,032,000 | 12.03% | ||
| 30 | IRONWOOD PHARMACEUTICALS INC | 2,855,515 | 43,661,000 | 14.58% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001140361-17-007745, filed 2017.02.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
